SU1352366A1 - Method of determining disease of horny layer of epidermis - Google Patents
Method of determining disease of horny layer of epidermis Download PDFInfo
- Publication number
- SU1352366A1 SU1352366A1 SU782703071A SU2703071A SU1352366A1 SU 1352366 A1 SU1352366 A1 SU 1352366A1 SU 782703071 A SU782703071 A SU 782703071A SU 2703071 A SU2703071 A SU 2703071A SU 1352366 A1 SU1352366 A1 SU 1352366A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- epidermis
- horny layer
- treatment
- staining
- determining disease
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Изобретение относитс к дерматологии . Цель изобретени - повышение точности способа. На кожу нанос т раствор азотнокислого серебра и уротропина. Поражение кожи определ ют по наличию потемневших участков кожи. После лечени провод т повторную регистрацию фотометрической контрастности .The invention relates to dermatology. The purpose of the invention is to improve the accuracy of the method. A solution of silver nitrate and hexamine is applied to the skin. Skin lesions are determined by the presence of darkened skin areas. After treatment, photometric contrast is re-recorded.
Description
Изобретение относитс к медицине, в частности к дерматологии.This invention relates to medicine, in particular to dermatology.
Целью изобретени вл етс повышение точности определени благодар Проведению прижизненной визуальной реакции рогового сло нормального и пораженного эпидермиса с 3%-ным серебр но-уротропиновым реактивом , котора регистрируетс в услови х сравнительной дифференциальной фотометрической контрастности.The aim of the invention is to improve the determination accuracy by conducting an in vivo visual reaction of the stratum corneum of the normal and affected epidermis with 3% silver urotropine reagent, which is recorded under conditions of comparative differential photometric contrast.
Способ осуществл ют следующим образом ,The method is carried out as follows.
До лечени после установлени диагноза у больного на видимо здоровую кожу и пораженный участок при помощи пипетки нанос т каплю раствора 3%-Horof азотнокислого серебра и 3%-ного уротропина,, вз тых в равных количествах (1 : 1 ) на площади 1,3 см и в виде круга. Через 20 - 30 мин происходит потемнение участков кожи. Таким образом устанавливают наличие поражений в роговом слое эпидермиса. Затем провод т избранную терапию, котора заключаетс в общем и местном лечении, .Общее лечение включает в себ назначение различных Лекарственньк препаратов (десенсиби- лизируклцие, витамины, гормоны и др.)Before treatment, after the patient was diagnosed, the apparently healthy skin and the affected area were pipetted with a drop of a solution of 3% -Horof silver nitrate and 3% hexamine, taken in equal amounts (1: 1) in an area of 1.3 see and in the form of a circle. After 20 - 30 minutes darkening of the skin occurs. Thus establish the presence of lesions in the stratum corneum of the epidermis. Then, the selected therapy is carried out, which consists in general and local treatment. The general treatment includes the appointment of various medications (desensitization, vitamins, hormones, etc.)
а местно примен ютс различные лекарственные формы (примочки, жидкие пасты , кремы и мази). Лечение провод т до полного исчезновени клинических признаков заболевани .35various topical forms (lotions, liquid pastes, creams and ointments) are applied topically. The treatment is carried out until the clinical signs of the disease disappear. 35
По завершении лечени экземы вновь нанос т 3%-ный серебр но-уротропино- вый реактив на два смежных участкаWhen the eczema treatment is completed, 3% silver-urotropin reagent is again applied to two adjacent sites.
Редактор И,РыбченкоEditor And, Rybchenko
Составитель М,Позн к Техред М,МоргенталCompiled by M, Pozn to Tehred M, Morgenthal
Заказ 5559/42Order 5559/42
Тираж 776ПодписноеCirculation 776 Subscription
ВНИИПИ Государственного комитета СССРVNIIPI USSR State Committee
по делам изобретений и открытий 113035, Москва, Ж-35, Раушска наб,, д,4/5 for inventions and discoveries 113035, Moscow, Zh-35, Raushsk nab ,, d, 4/5
Производственно-полиграфическое предпри тие, г.Ужгород, ул.Проектна , 4Production and printing company, Uzhgorod, Projecto st., 4
5five
00
5five
00
5five
кожи и провод т повторную регистрацию сравнительной дифференциальной фотометрической контрастности. Данные , полученные до лечени и после его завершени , сравнивают.skin and re-register a comparative differential photometric contrast. The data obtained before and after treatment are compared.
Клинические исследовани проведены на 12 больньпс, страдающих истинной экземой, которые показали, что до лечени показатель сравнительной диффренциальной фотометрической контрастности был в среднем равен 30 - 40%, После лечени у больных на пораженной коже отмечалось усиление прокрашивани и вместе с тем уменьшилс показатель сравнительной дифференциальной фотометрической контрастности до 10-12%, Отмечена пр ма зависимость показател сравнительной дифференциальной контрастности с исчезновением клинических признаков заболевани .Clinical studies were conducted on 12 patients suffering from true eczema, which showed that, prior to treatment, the comparative differential photometric contrast ratio was on average 30–40%. contrast up to 10-12%. A direct dependence of the comparative differential contrast ratio with the disappearance of clinical signs of the disease was noted.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU782703071A SU1352366A1 (en) | 1978-12-28 | 1978-12-28 | Method of determining disease of horny layer of epidermis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU782703071A SU1352366A1 (en) | 1978-12-28 | 1978-12-28 | Method of determining disease of horny layer of epidermis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1352366A1 true SU1352366A1 (en) | 1987-11-15 |
Family
ID=20801203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU782703071A SU1352366A1 (en) | 1978-12-28 | 1978-12-28 | Method of determining disease of horny layer of epidermis |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU1352366A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1306658A3 (en) * | 2001-10-29 | 2003-09-24 | Pola Chemical Industries, Inc. | Method for preparing corneocyte specimens and staining corneocytes, and skin analysis system |
-
1978
- 1978-12-28 SU SU782703071A patent/SU1352366A1/en active
Non-Patent Citations (1)
| Title |
|---|
| Вахерт A.M. и др. Атлас диагностических биопсий кожи. Медицина, 1971, с. 1 1 . Левер Ч.Ф. Гистологи кожи. М.: Медгиз, 1958, с. 113. * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1306658A3 (en) * | 2001-10-29 | 2003-09-24 | Pola Chemical Industries, Inc. | Method for preparing corneocyte specimens and staining corneocytes, and skin analysis system |
| EP1845359A3 (en) * | 2001-10-29 | 2007-11-14 | Pola Chemical Industries, Inc. | Method for preparing corneocyte specimens and staining corneocytes, and skin analysis system |
| US7421105B2 (en) | 2001-10-29 | 2008-09-02 | Pola Chemical Industries Inc. | Method for staining corneocytes, method for preparing corneocytes specimen and skin analysis system |
| US7425427B2 (en) | 2001-10-29 | 2008-09-16 | Pola Chemical Industries Inc. | Method for staining corneocytes, method for preparing corneocytes specimen and skin analysis system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bahr | Osmium tetroxide and ruthenium tetroxide and their reactions with biologically important substances: electron stains III | |
| Fiedler et al. | Treatment-resistant alopecia areata: response to combination therapy with minoxidil plus anthralin | |
| Tomokuni et al. | Direct colorimetric determination of hippuric acid in urine | |
| Chung et al. | Kinetics of the hydrolysis of pilocarpine in aqueous solution | |
| Javanbakht et al. | A selective and sensitive voltammetric sensor based on molecularly imprinted polymer for the determination of dipyridamole in pharmaceuticals and biological fluids | |
| SU1352366A1 (en) | Method of determining disease of horny layer of epidermis | |
| Cinnamaldehyde | Cross-sensitization patterns in guinea pigs between cinnamaldehyde, cinnamyl alcohol and cinnamic acid | |
| Li et al. | An activatable photoacoustic probe for imaging upregulation of hydrogen sulfide in inflammation | |
| DE2503993A1 (en) | METHOD FOR THE SIMULTANEOUS DETERMINATION OF TRIGLYCERIDES, CHOLESTEROL AND PHOSPHOLIPIDS | |
| Lerner | Effect of ions on melanin formation | |
| Lowe et al. | New coal tar extract and coal tar shampoos: Evaluation by epidermal cell DNA synthesis suppression assay | |
| Maibach | Cheilitis: occult allergy to cinnamic aldehyde. | |
| Hughes et al. | Clinical response and tissue effects of etretinate treatment of patients with solar keratoses and basal cell carcinoma | |
| Fredriksson | Antipsoriatic activity of retinoic acid (vitamin A acid) | |
| Elliott et al. | The effects of insulin, metrazol, and electric shock on blood pyruvate, lactate, and glucose | |
| Farmer et al. | Invalidation of plasma ascorbic acid values by use of potassium cyanide | |
| Hernandez-Perez | Tretinoin therapy for monilethrix | |
| Martens-Lobenhoffer et al. | Long-term stability of 8-methoxypsoralen in ointments for topical PUVA therapy (‘Cream-PUVA’) | |
| Cotterill et al. | Short Papers: Aspects of Polymorph Function in Psoriasis | |
| Ennever | Phototherapy in a new light | |
| McDonagh et al. | Mechanism of phototherapy of neonatal jaundice. Regiospecific photoisomerization of bilirubins | |
| Needham | Properties of the connective tissue pigment of Lithobius forficatus (L.) | |
| Ylikorkala et al. | The effect of age on circulating 6-keto-prostaglandin F1a in humans | |
| Koch et al. | Allergic contact dermatitis from purified eosin | |
| Hanna et al. | Human urinary excretion of piperazine citrate from syrup formulations |